Mexico Country Commercial Guide
Learn about the market conditions, opportunities, regulations, and business conditions in mexico, prepared by at U.S. Embassies worldwide by Commerce Department, State Department and other U.S. agencies’ professionals
Select Country Guide
Healthcare Products & Services
Last published date:

Overview

Mexico’s healthcare sector is large and growing, representing a strong commercial opportunity for U.S. exporters. The system is composed of public and private providers, with approximately 70 percent of the population covered through public institutions such as Mexican Social Security Institute (IMSS), Institute for Social Security and Services for State Workers (ISSSTE), and the newly created IMSS Bienestar system. The private healthcare sector continues to expand in urban areas, driven by middle and high-income populations seeking higher quality care.

Public healthcare spending is expected to increase as the Mexican Government continues to consolidate purchasing and expand service coverage through IMSS Bienestar. However, long regulatory approval timelines, especially for medical devices and pharmaceuticals, create market access barriers for U.S. firms. U.S. products are perceived as high quality, innovative, and trustworthy, giving exporters a competitive advantage despite increased price competition from Asian, and particularly Chinese, suppliers.

Mexico relies heavily on imports of advanced medical equipment, diagnostics, and pharmaceutical ingredients. This dependency underscores the country’s need for more resilient and affordable supply chains, which is a top U.S. Government priority. Mexico is the largest medical device exporter in Latin America and the eighth largest globally, with most production destined for the United States. This supply chain integration makes Mexico a critical partner in supporting U.S. manufacturing jobs and maintaining regional competitiveness.

Trade Statistics

Table: Healthcare Market Size (USD Billions)

 20202021202220232024 (est.)
Total Imports12.111.210.2510.9210.55
Imports from the United States2.572.752.552.722.77
Total Exports7.387.938.48.919.49
Exchange Rates2020.320.1218.417.5

Source: Secretaría de Economía (SIAVI), Global Trade Atlas, industry estimates

Leading Sub-sectors

  • Medical Devices and Diagnostics: diagnostic imaging, patient monitoring, and minimally invasive surgical tools
  • Biopharmaceuticals: innovative drugs and biosimilars
  • Digital Health/HealthTech: Telemedicine and electronic health records (EHR)
  • Cold Chain Logistics and Supply Chain Resilience: Safe delivery of pharmaceuticals and biologics
  • Clinical Trials and Regulatory Innovation 
     

Opportunities

  • Supply Chain Diversification: Nearshoring manufacturing to reduce dependency on Asia
  • Foreign Investment into the USA: Mexican firms investing in the U.S. health sector
  • Digital Health Integration: Adoption of U.S. platforms for hospital IT and monitoring
  • Healthcare Infrastructure Projects: New hospitals via public-private partnerships
  • Countering PRC Influence: Preference for U.S. products due to quality and compliance advantage

Resources

  • COFEPRIS Comisión Federal para la Protección contra Riesgos Sanitarios
  • IMSS Bienestar
  • AMIIF, CANIFARMA, AMID
  • HealthTech Mexico/Fundación Slim Salud

Events

  • Greater New York Dental Meeting, November 28 - December 3, 2026. New York.
  • World Health Expo: June 17-19, 2026. Miami. 

Commercial Specialist

For more information on healthcare products and services in Mexico, contact: Juan Carlos Ruiz (JuanCarlos.Ruiz@trade.gov).

×

Global Business Navigator Chatbot Beta

Welcome to the Global Business Navigator, an artificial intelligence (AI) Chatbot from the International Trade Administration (ITA). This tool, currently in beta version testing, is designed to provide general information on the exporting process and the resources available to assist new and experienced U.S. exporters. The Chatbot, developed using Microsoft’s Azure AI services, is trained on ITA’s export-related content and aims to quickly get users the information they need. The Chatbot is intended to make the benefits of exporting more accessible by understanding non-expert language, idiomatic expressions, and foreign languages.

Limitations

As a beta product, the Chatbot is currently being tested and its responses may occasionally produce inaccurate or incomplete information. The Chatbot is trained to decline out of scope or inappropriate requests. The Chatbot’s knowledge is limited to the public information on the Export Solutions web pages of Trade.gov, which covers a wide range of topics on exporting. While it cannot provide responses specific to a company’s product or a specific foreign market, its reference pages will guide you to other relevant government resources and market research. Always double-check the Chatbot’s responses using the provided references or by visiting the Export Solutions web pages on Trade.gov. Do not use its responses as legal or professional advice. Inaccurate advice from the Chatbot would not be a defense to violating any export rules or regulations.

Privacy

The Chatbot does not collect information about users and does not use the contents of users’ chat history to learn new information. All feedback is anonymous. Please do not enter personally identifiable information (PII), sensitive, or proprietary information into the Chatbot. Your conversations will not be connected to other interactions or accounts with ITA. Conversations with the Chatbot may be reviewed to help ITA improve the tool and address harmful, illegal, or otherwise inappropriate questions.

Translation

The Chatbot supports a wide range of languages. Because the Chatbot is trained in English and responses are translated, you should verify the translation. For example, the Chatbot may have difficulty with acronyms, abbreviations, and nuances in a language other than English.

Privacy Program | Information Quality Guidelines | Accessibility